Avid Bioservices Inc (CDMO)

[vinmantoo]

that was exactly the kind of thing we were all told to believe about the PII 2nd ln NSCLC PII data that suffered the dose switching by our CRO, CSM in Fargo.

The FDA was NEVER going to accept the PII data because of the DOSE SWITCHING.

Wow, are you really comparing getting a go ahead for a phase III trial with an unprecedented alteration of FDA process to get Bavi approved? You aren't expecting FDA to make the unprecedented alteration of FDA process when the only controlled Bavi phase III trial was stopped at the first look in for futility, are you? What can't you understand? There isn't a single robust phase III data set, controlled or uncontrolled, and there won't be unless PPHM starts an entirely new trial. There is nothing for the FDA to review. Just wow!!